📋 PULSE BIOSCIENCES, INC. (PLSE) - Financial Results
Filing Date: 2026-05-04
Accepted: 2026-05-04 09:16:42
Event Type: Financial Results
Event Details:
PULSE BIOSCIENCES, INC. (PLSE) Reports the reporting period Financial Results
PULSE BIOSCIENCES, INC. (PLSE) announced its financial results for the period ending the reporting period.
Key Financial Highlights:
Revenue: 326
Net Income: Not disclosed
EPS: Not disclosed
Cash and equivalents: 68319
breaking data at Heart Rhythm
The expanded data set included increased evaluable patient counts from the first
human European feasibility study showing sustained 100% procedural success by Holter monitor at 6 months (95/95 evaluable patients), 96% procedural success by Holter monitor at 12 months (51/53), and 90% Kaplan
📋 PULSE BIOSCIENCES, INC. (PLSE) - Financial Results
Filing Date: 2026-05-04
Accepted: 2026-05-04 09:16:42
Event Type: Financial Results
Event Details:
📊 Key Financial Metrics (Year-over-Year Comparison):
💼 Business Developments:
Structured Data: